> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Workshop on Pediatric Drug Development for Heart Failure
- URL: https://www.fdaweb.com/workshop-on-pediatric-drug-development-for-heart-failure/
- Published: 2017-09-21T12:00:00.000Z
- Updated: 2026-09-14T22:51:51.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5139683

*Federal Register* notice: FDA has announced a 10/27 public workshop entitled “FDA-University of Maryland CERSI Drug Development in Pediatric Heart Failure: Extrapolation, Clinical Trial Design, and Endpoints.” The meeting is intended to address challenges related to the evaluation of products in pediatric heart failure including study population, endpoints, and extrapolating adult efficacy data. It will also discuss the use of registry data, and alternative trial designs and statistical methods. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2017-09-21/pdf/2017-20106.pdf?ref=fdaweb.com).